The studies described above provide a strong preclinical foundation for accelerating the development of a therapeutic human vaccine for Chagas disease. The authors are currently working to produce ...

As a deliverable, the advancement in development of an urgently needed new medical intervention, a therapeutic vaccine for Chagas disease, one of the most important neglected tropical diseases in ...

The General Directorate of Epidemiology reported low incidences of dengue, cholera, and leptospirosis, as can be seen in ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...

Trypanosomes are parasites that cause sleeping sickness, Chagas disease, and various animal diseases. Diagnosis and treatment remain complex and no effective vaccine has been developed.

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...

but millions of people are still estimated to be infected with Chagas disease. Diagnosis and treatment remain complex, and no effective vaccine has been developed for these neglected tropical ...

Because VLPs contain no virus genetic material, the vaccine cannot infect cells, reproduce or cause disease ... 4 Ribas Freitas AR, Pinheiro Chagas AA, Siqueira AM, Pamplona de Góes Cavalcanti ...

The initiative will focus on vaccines and medicines for diseases ... says it has earmarked $100 million for new treatments for Chagas disease, leishmaniasis, dengue fever and cryptosporidiosis ...

While snakes don't make the cut, these creatures that are the world's deadliest animals can lead to untold death and destruction on their own.

millions of people are still believed to be affected by Chagas disease. These neglected tropical diseases pose significant challenges, as diagnosis and treatment are complex, and no effective vaccine ...